- Home
- BCTX vs YQ Comparison
BCTX vs YQ Comparison
Compare BCTX & YQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- YQ
- Stock Information
- Founded
- BCTX 2014
- YQ 2012
- Country
- BCTX Canada
- YQ China
- Employees
- BCTX N/A
- YQ N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- YQ Other Consumer Services
- Sector
- BCTX Health Care
- YQ Real Estate
- Exchange
- BCTX Nasdaq
- YQ Nasdaq
- Market Cap
- BCTX 15.8M
- YQ 15.7M
- IPO Year
- BCTX N/A
- YQ 2020
- Fundamental
- Price
- BCTX $3.85
- YQ $1.54
- Analyst Decision
- BCTX Strong Buy
- YQ
- Analyst Count
- BCTX 1
- YQ 0
- Target Price
- BCTX $32.00
- YQ N/A
- AVG Volume (30 Days)
- BCTX 45.7K
- YQ 30.0K
- Earning Date
- BCTX 03-12-2025
- YQ 06-04-2025
- Dividend Yield
- BCTX N/A
- YQ N/A
- EPS Growth
- BCTX N/A
- YQ N/A
- EPS
- BCTX N/A
- YQ N/A
- Revenue
- BCTX N/A
- YQ $25,922,648.00
- Revenue This Year
- BCTX N/A
- YQ N/A
- Revenue Next Year
- BCTX N/A
- YQ N/A
- P/E Ratio
- BCTX N/A
- YQ N/A
- Revenue Growth
- BCTX N/A
- YQ 10.68
- 52 Week Low
- BCTX $0.35
- YQ $1.43
- 52 Week High
- BCTX $7.87
- YQ $3.19
- Technical
- Relative Strength Index (RSI)
- BCTX 50.94
- YQ 40.05
- Support Level
- BCTX $3.44
- YQ $1.50
- Resistance Level
- BCTX $4.36
- YQ $1.89
- Average True Range (ATR)
- BCTX 0.38
- YQ 0.26
- MACD
- BCTX -0.05
- YQ -0.05
- Stochastic Oscillator
- BCTX 35.42
- YQ 8.88
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About YQ 17 Education & Technology Group Inc.
17 Education & Technology Group Inc is an education technology company in China. It offers to assist students, teachers, schoolmasters, and educational authorities across China to achieve data-driven teaching, learning, and assessment. Geographically group operates in China.